An announcement from Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) is now available.
Recordati announced the availability of the Directors’ Report related to the appointment of the Board of Directors, ahead of the Ordinary Shareholders’ Meeting scheduled for April 29, 2025. This move underscores the company’s commitment to transparency and governance, potentially impacting its operations and stakeholder relations positively.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati Industria Chimica e Farmaceutica S.p.A. is an international pharmaceutical group listed on the Italian Stock Exchange, with a history rooted in a family pharmacy in Northern Italy in the 1920s. The company provides therapeutic options in specialty and general medicine, as well as rare diseases, operating in a fully integrated manner from clinical development to production, marketing, and licensing. Recordati is present in about 150 countries across EMEA, Americas, and APAC regions, employing over 4,450 people.
YTD Price Performance: 5.34%
Average Trading Volume: 34,761
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: €11.03B
Learn more about REC stock on TipRanks’ Stock Analysis page.